DermTech Unternehmenswert
Was ist das Unternehmenswert von DermTech?
Unternehmenswert von DermTech, Inc. ist -$57.97
Was ist die Definition von Unternehmenswert?
Der Unternehmenswert ist ein Maß für den gesamten Marktwert eines Unternehmens. Es wird als Marktkapitalisierung mit Verschuldung, Minderheitsanteilen und Vorzugsaktien abzüglich der Zahlungsmittel und Zahlungsmitteläquivalente berechnet.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Unternehmenswert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu DermTech
Was macht DermTech?
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers Pigmented Lesion Assay (PLA), a gene expression test that helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides Nevome test, an adjunctive reflex test for the PLA; and adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Unternehmen mit unternehmenswert ähnlich DermTech
- Viomi Technology Co., Ltd hat Unternehmenswert von -$62.05
- Tian Ge Interactive hat Unternehmenswert von -$61.08
- Spruce Biosciences hat Unternehmenswert von -$59.37
- Novacyt S.A hat Unternehmenswert von -$59.25
- Novacyt S.A hat Unternehmenswert von -$58.46
- Technip Energies N.V hat Unternehmenswert von -$58.13
- DermTech hat Unternehmenswert von -$57.97
- Blue Sky Alternatives Access Fund Ltd hat Unternehmenswert von -$57.88
- Plato Income Maximiser hat Unternehmenswert von -$57.22
- Novacyt S.A hat Unternehmenswert von -$56.75
- Tomson hat Unternehmenswert von -$56.61
- Shandong International Trust Co hat Unternehmenswert von -$55.99
- B.S.D Crown hat Unternehmenswert von -$55.61